PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY

PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY

Bibliographic Details
Main Authors:	Elena Crisà, Annamaria Nosari, Daniela Cilloni, Sam Salek, Tatyana Ionova, Matteo Giovanni Della Porta, Maria Teresa Voso, Luca Maurillo, Carlo Finelli, Valeria Santini, Enrico Balleari, Federica Pilo, Giuseppe Palumbo, Alfredo Molteni, Marta Riva, Esther Oliva
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000977364.97921.83

Similar Items

2.672 Projects Laboratory, Spring 2004
by: Cheng, Wai Kong, et al.
Published: (2010)

The electric vehicle experiment : developing the theoretical model for 2.672
by: Zedler, Matthew R. (Matthew Robert)
Published: (2008)

2.672 experiment design : heat sink fin configurations
by: Reynolds, Zachary W. (Zachary William)
Published: (2008)

Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms
by: Esther Natalie Oliva, et al.
Published: (2025-02-01)

Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
by: Mario Cazzola
Published: (2011-03-01)

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience
by: Sandra Mossuto, et al.
Published: (2020-10-01)

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
by: Luca Malcovati, et al.
Published: (2014-11-01)

Molecular basis of myelodysplastic/myeloproliferative neoplasms
by: Andreas Reiter, et al.
Published: (2009-12-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
by: Malcovati, L, et al.
Published: (2011)

Iron Chelation Therapy in Myelodysplastic Syndromes
by: Emanuela Messa, et al.
Published: (2010-01-01)

The immunobiology of myelodysplastic neoplasms: a mini-review
by: Shruthi Kannan, et al.
Published: (2024-09-01)

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms
by: Luca L. G. Janssen, et al.
Published: (2024-07-01)

Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
by: Thomas Ernst, et al.
Published: (2010-09-01)

P1705: PATIENT-REPORTED OUTCOMES IN MYELOPROLIFERATIVE NEOPLASMS IN CLINICAL TRIALS: A SYSTEMATIC REVIEW
by: E. N. Oliva, et al.
Published: (2022-06-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Francesco D'Alò, et al.
Published: (2010-08-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Mariangela Greco, et al.
Published: (2010-05-01)

Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape
by: Daniel Karel, et al.
Published: (2024-04-01)

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms
by: Rami Abdulbaki, et al.
Published: (2024-04-01)

Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS)
by: Josephine Lucero, et al.
Published: (2023-06-01)

CONTRIBUTION OF SOMATIC MUTATIONS IN THE RISK STRATIFICATION OF MYELODYSPLASTIC NEOPLASMS
by: FK Marques, et al.
Published: (2023-10-01)

Myelodysplastic syndrome/myeloproliferative neoplasm with ringed sideroblasts and thrombocytosis
by: Azka Tasleem, et al.
Published: (2021-11-01)

Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms
by: Michael J. Hochman, et al.
Published: (2021-08-01)

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
by: Adrian Mosquera Orgueira, et al.
Published: (2023-10-01)

P1724: QUALITY OF LIFE AND UNMET NEEDS AMONG PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM PATIENTS: RESULTS OF THE NATIONWIDE SURVEY
by: T. Ionova, et al.
Published: (2022-06-01)

Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium
by: Cristina A. Tentori, et al.
Published: (2024-05-01)

Prevalenza dei sintomi vertigine e instabilità in un campione di 2672 soggetti e correlazione con il sintomo cefalea
by: R. Teggi, et al.
Published: (2016-05-01)

Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms
by: Zdenek Krejcik, et al.
Published: (2025-01-01)

Myelodysplastic Neoplasms: The Impact of Clonality on Inflammatory-Degenerative Diseases of the Elderly
by: Nicolas Bonadies
Published: (2024-03-01)

The consensus on the diagnosis and treatment of elderly myelodysplastic neoplasm in China (2024)
by: MDS Professional Committee of Hematology Branch of Chinese Geriatrics Society
Published: (2024-06-01)

Luspatercept: A peaceful revolution in the standard of care for myelodysplastic neoplasms
by: Francesca Vinchi, et al.
Published: (2024-03-01)

CHILDHOOD MYELODYSPLASTIC NEOPLASM: GENETIC VARIANTS AND THEIR IMPACT ON DIAGNOSIS AND PROGNOSIS
by: Viviane Lovatel, et al.
Published: (2023-12-01)

IMPACT PROGNOSIS OF CYTOGENETIC ALTERATIONS IN BRAZILIAN CHILDHOOD MYELODYSPLASTIC NEOPLASM
by: Viviane Lovatel, et al.
Published: (2023-12-01)

How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
by: Carmelo Gurnari, et al.
Published: (2022-12-01)

Molecular Drivers of Myelodysplastic Neoplasms (MDS)—Classification and Prognostic Relevance
by: Fieke W. Hoff, et al.
Published: (2023-02-01)

HYPERMETHYLATION OF DNA REPAIR GENES IS LINKED TO PROGNOSIS OF MYELODYSPLASTIC NEOPLASM
by: MA Viana, et al.
Published: (2023-10-01)

Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes
by: Joseph A. Clara, et al.
Published: (2016-09-01)

Outcome of therapy-related myeloid neoplasms treated with azacitidine
by: Fianchi Luana, et al.
Published: (2012-08-01)

Myelodysplastic Syndromes and Myelodysplastic Syndromes/Myeloproliferative Neoplasms: A Real-World Experience From a Developing Country
by: Abdalla Awidi, et al.
Published: (2024-02-01)

Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in Sweden
by: Osama Hamida, et al.
Published: (2024-12-01)